Biomarkers in Parkinson's disease.
Parkinson's disease (PD) is a common neurodegenerative disorder that is largely diagnosed and managed clinically. Biomarkers, as indicators of underlying biological processes, offer the potential to identify individuals at risk for PD, screen new therapies, assist in the diagnosis and help optimize management of PD. However, to date, biomarkers, despite their considerable promise, have had limited utility in clinical trials and practice.
Dorsey
E Ray
ER
University of Rochester Medical Center, 1351 Mt. Hope Avenue, Suite 223, Rochester, NY 14620, USA. ray.dorsey@ctcc.rochester.edu
Holloway
Robert G
RG
Ravina
Bernard M
BM
D015415:Biomarkers / Q000378:metabolism; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism
D015415:Biomarkers